- 2015
-
Press releases - 26.03.2015
What if the severity of our seasonal influenza were related to our genetic background?
By analysing the genome of a little girl who contracted a severe form of influenza at the age of two and a half years, researchers have discovered that she has a genetic mutation, unknown until now, that causes a subtle dysfunction in her immune system.
-
Press releases - 26.03.2015
A pharmacological compound for restoring neuromuscular transmission
Researchers from Inserm, CNRS and Paris Descartes University have just demonstrated the beneficial effect of lithium chloride on a group of genetic disorders responsible for muscle dysfunction known as congenital myasthenias.
-
Press releases - 24.03.2015
Friday 27 March 2015: Sleep Day
On the 15th Sleep Day, to be held on Friday 27 March 2015 on the theme of “Sleep and Nutrition,” many public institutions and associations, including InSV, will be working to receive, inform and sensitise the general public.
-
What's on? - 24.03.2015
Friday 27 March 2015: Sleep Day
According to the French National Institute of Sleep and Alertness (InSV), 1 French person in 5 suffers from insomnia, and up to 9% of these insomniacs are badly affected (poor quality sleep, difficulty falling asleep, multiple awakenings or waking too early). Indeed, sleep is indispensable to the learning, memorisation, adaptation and growth functions, and is also […]
-
Press releases - 24.03.2015
Targeting a host receptor instead of the virus: a new experimental approach against hepatitis C virus.
Une collaboration internationale conduite par le Professeur Thomas Baumert met en évidence qu’un anticorps monoclonal spécifiquement dirigé contre la claudine-1, permet de prévenir et de traiter une infection chronique par ce virus dans un modèle animal.
-
News in brief - 24.03.2015
Fatty plaques in the arteries associated with dementia in older subjects
The carotid arteries are essential for supplying blood to the brain. In a study published online in the journal Alzheimer’s & Dementia, researchers from Inserm, in collaboration with those involved in the Three Cities Study (3C), have focused on the relationships between atherosclerosis and the risk of dementia in older subjects. Atherosclerosis is characterised by […]
-
Press releases - 23.03.2015
Predicting the end of fertility for women after paediatric cancer
Researchers from the Paris Public Hospitals (AP-HP), Inserm, the Gustave Roussy and Curie Institutes, and Oscar Lambret Cancer Centre, coordinated by Dr Cécile Thomas-Teinturier of the Paediatric Endocrinology Service at Bicêtre Hospital, have studied the impact of certain therapeutic agents on the fertility of women who have been cured of a paediatric cancer.
-
Press releases - 19.03.2015
Solar eclipse on 20 March: dangers for the retina
On Friday 20 March 2015, a partial eclipse of the sun will be visible in France between 9:00 and 12:00 am, depending on the place of observation. Why is looking directly at the sun dangerous and a cause of irreversible damage to the retina? Inserm researchers who are specialists at the Vision Institute (Inserm/CNRS/UPMC) can answer your questions.
-
What's on? - 19.03.2015
Solar eclipse on 20 March: dangers for the retina
On Friday 20 March 2015, a partial eclipse of the sun will be visible in France between 9:00 and 12:00 am, depending on the place of observation. Why is looking directly at the sun dangerous and a cause of irreversible damage to the retina? Inserm researchers who are specialists at the Vision Institute (Inserm/CNRS/UPMC) can […]
-
Press releases - 18.03.2015
Manaslu 2015: A scientific expedition at over 5,000 m altitude
For 5 weeks, 5 international research teams will conduct a scientific expedition in Nepal, in the heart of the Himalayas, close to the summit of Mount Manaslu (8,156 m). The French component of the expedition, coordinated by a researcher from Inserm (Inserm/Université Joseph Fourier), will conduct an original project on the impact of altitude on the brain and heart, and on sleep disturbances induced by altitude. The French researchers will also study the benefit of a mask specially designed to improve oxygenation in combating the symptoms of acute mountain sickness. To do this, 50 volunteers will accompany them on this 5,000 m high trek.